Men, baby boomers, and postgraduate-degree holders were among those most likely to say they wouldn’t choose medication over ...

Wegovy has quickly gained popularity as a highly effective weight loss medication, but it's not always accessible due to the ...

Allowing Medicare to cover popular weight loss drugs such as Wegovy and Zepbound could increase federal spending by billions ...

The embattled diet brand said it is adding a compounded weight-loss drug in accordance with FDA rules and manufacturing ...

Unlike Ozempic, Wegovy is approved for weight management even though they both contain semaglutide. However, they do have ...

Novo Nordisk (NVO) and Viatris (VTRS) have reportedly reached an agreement in their dispute over U.S. patents protecting Novo ...

Some people have turned to compound pharmacies to replace drugs in short supply, but medical professionals warn of a new ...

U.S. representative from Austin asks Health and Human Services secretary to push for generic licensing of semaglutide ...

A new trial reveals that weekly injections of the weight-loss drug Wegovy (semaglutide) lowered the risk of death from COVID-19 by about a third and reduced overall mortality by 19%.

Medicare covers Wegovy as a treatment to reduce the risk of serious cardiovascular events in people who have overweight or obesity. It does not cover Wegovy for weight loss.

State workers’ access to weight loss drugs has put House Speaker Tim Moore at odds with State Treasurer Dale Folwell, who ran ...

On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard ...